SCHEME 1. Discon n ection Ap p r oa ch es to
Isop r en oid Na tu r a l P r od u cts Con ta in in g a
p-Qu in on e Hea d Gr ou p
Th e F r ied el-Cr a fts Allyla tion of a P r en yl
Gr ou p Sta bilized by a Su lfon e Moiety:
Exp ed itiou s Syn th eses of Ubiqu in on es a n d
Men a qu in on es
J ae-Hong Min, J un-Sup Lee, J ae-Deuk Yang, and
Sangho Koo*
Department of Chemistry, Myong J i University, Yongin,
Kyunggi-Do, 449-728, Korea
sangkoo@mju.ac.kr
Received J uly 14, 2003
Abstr a ct: An efficient synthetic method for the protected
p-hydroquinone compounds 4 containing the C5 trans allylic
sulfone moiety has been developed by the direct Friedel-
Crafts allylation of the protected dihydroquinone 2 with
4-chloro-2-methyl-1-phenylsulfonyl-2-butene (7a ) or 4-hy-
droxy-2-methyl-1-phenylsulfonyl-2-butene (7b). Expeditious
total syntheses of coenzyme Q-10 and vitamin K2(20) have
been demonstrated from these valuable key compounds 4a
and 4b.
intrinsic instability problems of polypreniol or the cor-
responding halide under acidic condition has not been
overcome. Coupling of the protected p-hydroquinone 4
containing the C5 allylic sulfone moiety and the polypre-
nyl chain 5 (X ) halogen) by the J ulia sulfone protocol6
(approach 2, Scheme 1), originally delineated by Terao
for coenzyme Q-10 synthesis,7 was an excellent method
in that not only a high yield of the coupling product was
Isoprenoid natural products containing a p-quinone
head group play important roles in biological processes
of higher plants and animals. Ubiquinones ubiquitously
exist in mitochondria of every cell to participate in the
electron transport process for respiration, thus producing
energy for living organisms.1 Coenzyme Q-10 (1a ), the
ubiquinone of humans, also has a treatment effect on
heart-related disease.2 Menaquinones, known as vitamin
K2 (1b), promote normal clotting of the blood.
There have been extensive synthetic efforts for these
indispensable natural products,3 where the key issue was
the coupling method of the quinone core and the poly-
prenyl side chain. Coupling of the p-hydroquinone 2 (P
) H) and the polyprenyl chain 3 (X ) OH or halogen) by
the Friedel-Crafts reaction (approach 1, Scheme 1) was
a straightforward method,4 which, however, suffered from
low yields especially due to cyclization within the poly-
prenyl side chain and cyclization of the coupling product
to form chromanol. Some modifications of this method
have appeared,5 but the stereoselectivity at 2∆ and the
2
obtained, but also the E-configuration at ∆ as well as at
the other double bonds was retained, which would
provide better biological activities. The more attractive
point of the above method is that solanesol, C45 all-E-
polyprenyl alcohol, that is readily obtained by extraction
from the leaves of tobacco or potato can be directly
utilized in the synthesis of coenzyme Q-10. The potential
of this approach then relied on the efficient preparation
of compound 4.
The first preparation of 4 (P ) benzyl, R ) OCH3) by
Terao7 from 2,3-dimethoxy-5-methyl-1,4-benzoquinone
(coenzyme Q-0) was lengthy and thus industrially inap-
plicable. A better procedure has been proposed by Fujita8
that made use of 4-chloro-2-methyl-1-phenylsulfonyl-2-
butene (7a ) (Scheme 2). 2,3-Dimethoxy-5-methyl-1,4-
hydroquinone 2 (P ) H, R ) OCH3), which was obtained
by reduction of coenzyme Q-0, was brominated at the
unsubstituted ring carbon. Protection of the hydro-
quinone as 2-methoxyethoxymethyl (MEM) ether to give
6 (P ) MEM, R ) OCH3) was followed by the Grignard
(1) (a) Thomson, R. H. Naturally Occurring Quinones; Academic
Press: New York, 1971. (b) Mitchell, P.; Moyle, J . Coenzyme Q; Lenaz,
G., Ed.; Wiely: Chichester, UK, 1985.
(2) Lenaz, G. Coenzyme Q, Biochemistry, Bioenergetics and Clinical
Applications of Ubiquinone; Wiley-Interscience: New York, 1982.
(3) (a) Lipshutz, B. H.; Kim, S.-K.; Mollard, P.; Stevens, K. L.
Tetrahedron 1998, 1241. (b) Lipshutz, B. H.; Bulow, G.; Fernandez-
Lazaro, F.; Kim, S.-K.; Lowe, R.; Mollard, P.; Stevens, K. L. J . Am.
Chem. Soc. 1999, 121, 11664. (c) Lipshutz, B. H.; Mollard, P.; Pfeiffer,
S. S.; Chrisman, W. J . Am. Chem. Soc. 2002, 124, 14282. (d) van Liemt,
W. B. S.; Steggerda, W. F.; Esmeijer, R.; Lugtenburg, J . Recl. Trav.
Chim. Pays-Bas 1994, 113, 153. (e) Inoue, S.; Yamaguchi, R.; Saito,
K.; Sato, K. Bull. Chem. Soc. J pn. 1974, 47, 3098. (f) Garc´ıas, X.;
Ballester, P.; Capo´, M.; Saa´, J . M. J . Org. Chem. 1994, 59, 5093. (g)
Sato, K.; Inoue, S.; Saito, K. J . Chem. Soc., Perkin Trans. 1 1973, 2289.
(h) Snyder, C. D.; Rapoport, H. J . Am. Chem. Soc. 1974, 96, 8046 (i)
Naruta, Y. J . Org. Chem. 1980, 45, 4097.
(5) (a) Hirschmann, R.; Miller, R.; Wendler, N. L. J . Am. Chem. Soc.
1954, 76, 4592. (b) Araki, S.; Manabe, S.; Butsugan, Y. Chem. Lett.
1982, 797.
(6) (a) J ulia, M.; Arnould, D. Bull. Soc. Chim. Fr. 1973, 743. (b) J ulia,
M.; Arnould, D. Bull. Soc. Chim. Fr. 1973, 746.
(7) Terao, S.; Kato, K.; Shiraishi, M.; Morimoto, H. J . Org. Chem.
1979, 44, 868.
(4) (a) Isler, O.; Ru¨egg, R.; Chopard-dit-J ean, L.; Winterstein, A.;
Wiss, O. Helv. Chim. Acta 1958, 41, 786. (b) Isler, O.; Doebel, K. Helv.
Chim. Acta 1954, 37, 225.
(8) (a) Fujita, Y.; Ishiguro, M.; Onishi, T.; Nishida, T. Synthesis 1981,
469. (b) Fujita, Y.; Ishiguro, M.; Onishi, T.; Nishida, T. Bull. Chem.
Soc. J pn. 1982, 55, 1325.
10.1021/jo0350155 CCC: $25.00 © 2003 American Chemical Society
Published on Web 09/09/2003
J . Org. Chem. 2003, 68, 7925-7927
7925